ArticleContraception2026
Fetal demise duration and bleeding outcomes at the time of dilation and evacuation.
Article in Contraception, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesTo examine associations between time from second trimester intrauterine fetal demise (IUFD) to dilation and evacuation (D&E) and bleeding complications. STUDY
designWe identified 197 patients scheduled for D&E for IUFD at a single academic institution between March 2011 to March 2025. IUFD duration was calculated by subtracting gestational age by fetal biometry from gestational age by obstetric dating, categorized into 0-14 days, 15-28 days, and >28 days. We examined the associations between IUFD duration and bleeding outcomes of disseminated intravascular coagulopathy (DIC) and hemorrhage (EBL >1000mL) using logistic regression.
resultsOf the 189 patients included, durations of fetal demise were 0-14 days (n=61, 32.3%), 15-28 days (n=77, 40.7%), and >28 days (n=51, 27.0%). Bleeding outcomes were 3.2% DIC (n=6) and 2.2% hemorrhage (n=4). Due to low bleeding outcomes, neither were significantly associated with IUFD duration. However, patients >28 days from IUFD had 2.45 higher odds of developing DIC (95% CI 0.2-27.8) and 2.45 higher odds of developing hemorrhage (95% CI 0.2-27.8) compared to patients 0-14 days from IUFD.
conclusionEstimated time from IUFD to D&E is not significantly associated with DIC or hemorrhage. We emphasize the safety of D&E for second trimester IUFDs, especially through the first four weeks of management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.